CHRISTINE EDWARDS: Open Payments
NPI 1477793396 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,723 in 111 payments from 31 companies in 2025. Trend: 2023 $1,258 · 2024 $3,077 · 2025 $7,723
Speaker / faculty: $4,500Food & beverage: $3,223
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $5,099 |
| UCB, Inc. | 16 | $752 |
| Organon LLC | 3 | $250 |
| Novartis Pharmaceuticals Corporation | 7 | $218 |
| LEO Pharma Inc. | 2 | $176 |
| GENZYME CORPORATION | 1 | $130 |
| Arcutis Biotherapeutics, Inc. | 2 | $114 |
| Axsome Therapeutics, Inc. | 6 | $114 |
| PFIZER INC. | 2 | $97 |
| Lilly USA, LLC | 4 | $90 |
Products named: SKYRIZI, RINVOQ, Bimzelx, VTAMA, VRAYLAR, DUPIXENT, Zoryve, ADBRY.
Industry payments across MO — which companies pay providers there.
